https://carolinaurologicresearchcenter.com/wp-content/uploads/ScienceDirectArticle.jpg250300CURC/wp-content/uploads/logo-1.pngCURC2017-02-20 08:27:282017-02-20 08:27:28Safety and Antitumour Activity of ODM-201 (BAY-1841788) in Chemotherapy-naïve and CYP17 Inhibitor-naïve Patients: Follow-up from the ARADES and ARAFOR Trials. with Dr. Neal Shore, MD
Neal D. Shore, MD, FACS, on BRCA1 and BRCA2 genetic testing as guidelines for...